Previously linked to leukemogenesis, RUNX3 overexpression in BCR::ABL cells was shown to protect these cells from Imatinib-induced apoptosis, involving RUNX3 in chronic myeloid leukemia persistence [9]. This evidence concerns the gene RUNX3 and chronic myelogenous leukemia, BCR-ABL1 positive.